The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak

Brain

Volumn 135, Issue 6, 2012, Pages 1850-1859

  Magnus, Tim ^a   Röther, Joachim ^b   Simova, Olga ^a   Meier Cillien, Maria ^b   Repenthin, Jonas ^c   Möller, Fabian ^a   Gbadamosi, Joystone ^a   Panzer, Ulf ^a   Wengenroth, Martina ^c   Hagel, Christian ^a   Kluge, Stefan ^a   Stahl, Rolf K ^a   Wegscheider, Karl ^a   Urban, Peter ^c   Eckert, Bernd ^b   Glatzel, Markus ^a   Fiehler, Jens ^a   Gerloff, Christian ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ASKLEPIOS KLINIK ALTONA   (Germany)

^c ASKLEPIOS HOSPITAL BARMBEK   (Germany)

Author keywords

encephalopathy; MRI; seizures; STEC

Indexed keywords

CREATININE;

ADULT; AGED; ANXIETY; APHASIA; ARTICLE; ATTENTION DISTURBANCE; COGNITIVE DEFECT; CREATININE BLOOD LEVEL; DIARRHEA; DISEASE COURSE; DISORIENTATION; ELECTROENCEPHALOGRAPHY; ESCHERICHIA COLI INFECTION; FEMALE; FOLLOW UP; GERMANY; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NERVOUSNESS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTROPISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; PRIORITY JOURNAL; RESTLESSNESS; SEIZURE; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; UREA NITROGEN BLOOD LEVEL;

EID: 84861547500     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/aws090     Document Type: Article

References (31)

1. Bale JF Jr, Brasher C, Siegler RL. CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis. Am J Dis Child 1980; 134: 869-72.
2. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 2004; 430: 257-63.
3. Boccoli J, Loidl CF, Lopez-Costa JJ, Creydt VP, Ibarra C, Goldstein J. Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibril-lary acidic protein in rat brains. Brain Res 2008; 1230: 320-33.
4. Dean-Nystrom EA, Pohlenz JF, Moon HW, O'Brien AD. Escherichia coli O157:H7 causes more-severe systemic disease in suckling piglets than in colostrum-deprived neonatal piglets. Infect Immun 2000; 68: 2356-8.
5. Dundas S, Todd WT, Stewart AI, Murdoch PS, Chaudhuri AK, Hutchinson SJ. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 2001; 33: 923-31.
6. Eriksson KJ, Boyd SG, Tasker RC. Acute neurology and neurophysiology of haemolytic-uraemic syndrome. Arch Dis Child 2001; 84: 434-5.
7. Frank C, Werber D, Cramer JP, Askar M, Faber M, Heiden MA, et al. Epidemic Profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany-preliminary report. N Engl J Med 2011; 365: 1771-80.
8. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 2002; 186: 493-500.
9. Goldstein J, Loidl CF, Creydt VP, Boccoli J, Ibarra C. Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study. Brain Res 2007; 1161: 106-15.
10. Gould LH, Demma L, Jones TF, Hurd S, Vugia DJ, Smith K, et al. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006. Clin Infect Dis 2009; 49: 1480-5.
11. Hahn JS, Havens PL, Higgins JJ, O'Rourke PP, Estroff JA, Strand R. Neurological complications of hemolytic-uremic syndrome. J Child Neurol 1989; 4: 108-13.
12. Hamano S, Nakanishi Y, Nara T, Seki T, Ohtani T, Oishi T, Joh K, et al. Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan. Acta Paediatr 1993; 82: 454-8.
13. Institut RK. Bericht: Abschließende Darstellung und Bewertung der epidemiologischen Erkenntnisse im EHEC O104:H4 Ausbruch [Final epidemiological report on the German O104:H4 EHEC crisis]. Deutschland; 2011. http://www.rki.de/cln-162/nn-205760/DE/Content/InfAZ/E/EHEC/EHEC- Abschlussbericht.html?-nnn=true.
14. Jeong YK, Kim IO, Kim WS, Hwang YS, Choi Y, Yeon KM. Hemolytic uremic syndrome: MR findings of CNS complications. Pediatr Radiol 1994; 24: 585-6.
15. Johannes L, Romer W. Shiga toxins-from cell biology to biomedical applications. Nat Rev Microbiol 2010; 8: 105-16.
16. Mizuguchi M, Tanaka S, Fujii I, Tanizawa H, Suzuki Y, Igarashi T, et al. Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system. Acta Neuropathol 1996; 91: 254-62.
17. Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, et al. Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 2010; 5: 1218-28.
18. Obata F, Obrig T. Distribution of Gb(3) immunoreactivity in the mouse central nervous system. Toxins 2010; 2: 1997-2006.
19. Obata F, Tohyama K, Bonev AD, Kolling GL, Keepers TR, Gross LK, et al. Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis 2008; 198: 1398-406.
20. Ren J, Utsunomiya I, Taguchi K, Ariga T, Tai T, Ihara Y, et al. Localization of verotoxin receptors in nervous system. Brain Res 1999; 825: 183-8.
21. Rohde H, Qin J, Cui Y, Li D, Loman NJ, Hentschke M, et al. Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4. N Engl J Med 2011; 365: 718-24.
22. Rolf AK Stahl, Hermann H, Jü rgen S, Elion H, Erik D, Christian K, et al. A Multi-Center Clinical Study of Eculizumab Treatment for Shiga-Toxin-Producing E. coli Hemolytic Uremic Syndrome (STEC-HUS). 2012 (in revision).
23. Scheutz F, Nielsen EM, Frimodt-Moller J, Boisen N, Morabito S, Tozzoli R, et al. Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. Euro Surveill 2011; 16: 19889.
24. Schmidt S, Gudinchet F, Meagher-Villemure K, Maeder P. Brain involvement in haemolytic-uraemic syndrome: MRI features of coagulative necrosis. Neuroradiology 2001; 43: 581-5.
25. Sheth KJ, Swick HM, Haworth N. Neurological involvement in hemolytic-uremic syndrome. Ann Neurol 1986; 19: 90-3.
26. Siegler RL. Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr 1994; 125: 511-8.
27. Siegler RL, Pysher TJ, Lou R, Tesh VL, Taylor FB Jr. Response to Shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome. Am J Nephrol 2001; 21: 420-5.
28. Steinborn M, Leiz S, Rudisser K, Griebel M, Harder T, Hahn H. CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr Radiol 2004; 34: 805-10.
29. Takahashi K, Funata N, Ikuta F, Sato S. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2. J Neuroinflammation 2008; 5: 11.
30. Taylor FB Jr, Tesh VL, DeBault L, Li A, Chang AC, Kosanke SD, et al. Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol 1999; 154: 1285-99.
31. Yamamoto T, Satomura K, Okada S, Ozono K. Risk factors for neurological complications in complete hemolytic uremic syndrome caused by Escherichia coli O157. Pediatr Int 2009; 51: 216-9.